OXT and pulmonary arterial hypertension: A network meta-analysis found that oxytocin is more effective than misoprostol for first-line treatment of PPH, with fewer adverse side-effects; addition of misoprostol to oxytocin has little or no benefit; and there is little robust evidence on other uterotonics such as ergometrine and injectable prostaglandins [8].